Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2019 Update

Summary

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research areas. Its clinical areas include bone metabolism, calcium metabolism, chronic kidney disease and mineral bone disorders, fertility, growth disorders, and cartilage markers. IDS offers IDS-iSYS multi-discipline automated system, an instrument based on chemiluminescence and absorbency technology to improve productivity and efficiency of specialty immunoassay testing in laboratories of all types and volumes. The company offers application training and advice, customized training, qualified customer care centers and regionalised proximity teams. It has operations in the UK, Italy, Australia, Japan, Germany, France, Norway, Belgium and the US. IDS is headquartered in Tyne and Wear, the UK.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Immunodiagnostic Systems Holdings plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company


List of Tables
List of Figures
Immunodiagnostic Systems Holdings plc Company Overview
Immunodiagnostic Systems Holdings plc Company Snapshot
Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview
Immunodiagnostic Systems Holdings plc Pipeline Analysis Overview
Immunodiagnostic Systems Holdings plc - Key Facts
Immunodiagnostic Systems Holdings plc - Major Products and Services
Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage
Immunodiagnostic Systems Holdings plc Pipeline Products Overview
IDS-i10 - Infectious Disease Assay
IDS-i10 - Infectious Disease Assay Product Overview
IDS-i10 - Allergy Assay
IDS-i10 - Allergy Assay Product Overview
IDS-i10 - Autoimmunity Assay
IDS-i10 - Autoimmunity Assay Product Overview
IDS-iSYS - 17-beta Estradiol Assay
IDS-iSYS - 17-beta Estradiol Assay Product Overview
IDS-iSYS - Androstenedione Assay
IDS-iSYS - Androstenedione Assay Product Overview
IDS-iSYS - DHEA-S
IDS-iSYS - DHEA-S Product Overview
IDS-iSYS - Total Testosterone Assay
IDS-iSYS - Total Testosterone Assay Product Overview
IDS-iSYS Bioactive PTH (1-84) Kit
IDS-iSYS Bioactive PTH (1-84) Kit Product Overview
IDS-iSYS Cortisol Assay
IDS-iSYS Cortisol Assay Product Overview
IDS-iSYS Free Testosterone Assay
IDS-iSYS Free Testosterone Assay Product Overview
IDS-iSYS MGP Assay
IDS-iSYS MGP Assay Product Overview
Immunodiagnostic Systems Holdings plc - Key Competitors
Immunodiagnostic Systems Holdings plc - Key Employees
Immunodiagnostic Systems Holdings plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Immunodiagnostic Systems Holdings plc, Recent Developments
Jun 19, 2019: Immunodiagnostic Systems Holdings: Final results for year ended 31 March 2019
Apr 18, 2019: Immunodiagnostic Systems Holdings: FY2019 trading update
Apr 01, 2019: THERADIAG signs a development and distribution agreement with IMMUNODIAGNOSTIC SYSTEMS
Oct 19, 2018: Immunodiagnostic Systems: H1 Trading Update
Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018
Apr 04, 2018: Meet IDS at MEDLAB Asia Pacific 2018 from the 2 nd until the 4 th of April
Mar 29, 2018: Immunodiagnostic Systems Holdings: Launch of two new automated assays
Mar 21, 2018: Immunodiagnostic Systems Holdings: Directorate Change 2018
Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017
Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

List of Tables
Immunodiagnostic Systems Holdings plc Pipeline Products and Ongoing Clinical Trials Overview
Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type
Immunodiagnostic Systems Holdings plc Pipeline Products by Indication
Immunodiagnostic Systems Holdings plc, Key Facts
Immunodiagnostic Systems Holdings plc, Major Products and Services
Immunodiagnostic Systems Holdings plc Number of Pipeline Products by Development Stage
Immunodiagnostic Systems Holdings plc Pipeline Products Summary by Development Stage
IDS-i10 - Infectious Disease Assay - Product Status
IDS-i10 - Infectious Disease Assay - Product Description
IDS-i10 - Allergy Assay - Product Status
IDS-i10 - Allergy Assay - Product Description
IDS-i10 - Autoimmunity Assay - Product Status
IDS-i10 - Autoimmunity Assay - Product Description
IDS-iSYS - 17-beta Estradiol Assay - Product Status
IDS-iSYS - 17-beta Estradiol Assay - Product Description
IDS-iSYS - Androstenedione Assay - Product Status
IDS-iSYS - Androstenedione Assay - Product Description
IDS-iSYS - DHEA-S - Product Status
IDS-iSYS - DHEA-S - Product Description
IDS-iSYS - Total Testosterone Assay - Product Status
IDS-iSYS - Total Testosterone Assay - Product Description
IDS-iSYS Bioactive PTH (1-84) Kit - Product Status
IDS-iSYS Bioactive PTH (1-84) Kit - Product Description
IDS-iSYS Cortisol Assay - Product Status
IDS-iSYS Cortisol Assay - Product Description
IDS-iSYS Free Testosterone Assay - Product Status
IDS-iSYS Free Testosterone Assay - Product Description
IDS-iSYS MGP Assay - Product Status
IDS-iSYS MGP Assay - Product Description
Immunodiagnostic Systems Holdings Plc, Key Employees
Immunodiagnostic Systems Holdings Plc, Subsidiaries
Glossary

List Of Figures

List of Figures
Immunodiagnostic Systems Holdings plc Pipeline Products by Equipment Type
Immunodiagnostic Systems Holdings plc Pipeline Products by Development Stage

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2019 Update

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone

USD 750 View Report

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2018 Update

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone

USD 750 View Report

Electro Optic Systems Holdings Ltd (EOS) - Financial and Strategic SWOT Analysis Review

Electro Optic Systems Holdings Ltd (EOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

Immunodiagnostic Systems Holdings plc (IDH) - Product Pipeline Analysis, 2018 Update

Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available